Clinical Trials
6 trialsNCT07475923 2026-04-16
Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)
M.D. Anderson Cancer Center
Withdrawn
NCT03121989 2023-03-30
LABC
Sunnybrook Health Sciences Centre
Phase 1 Withdrawn
NCT00397761 2021-02-17
Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer
Medstar Health Research Institute
Phase 2/3 Withdrawn
NCT03323424 2020-01-30
IRAM
Institut de Cancérologie de la Loire
Phase 2 Withdrawn
NCT00635245 2015-03-11
CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery
Pfizer
Phase 1 Withdrawn
NCT00080613 2013-07-10
Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn